tiprankstipranks
Savara (SVRA)
NASDAQ:SVRA

Savara Stock Analysis & Ratings

SVRA Stock Chart & Stats

Day’s Range$1.11 - $1.27
52-Week Range$1.02 - $1.91
Previous Close$1.14
Volume338.41K
Average Volume (3M)144.80K
Market Cap$142.55M
P/E Ratio-4.2
Beta1.06
Next EarningsAug 11, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score5
EPS (TTM)-0.29


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

SVRA FAQ

What was Savara’s price range in the past 12 months?
Savara lowest stock price was $1.02 and its highest was $1.91 in the past 12 months.
    What is Savara’s market cap?
    Savara’s market cap is $142.55M.
      What is Savara’s price target?
      The average price target for Savara is $3.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $3.00 ,the lowest forecast is $3.00. The average price target represents 140.00% Increase from the current price of $1.25.
        What do analysts say about Savara?
        Savara’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
          When is Savara’s upcoming earnings report date?
          Savara’s upcoming earnings report date is Aug 11, 2022 which is in 87 days.
            How were Savara’s earnings last quarter?
            Savara released its earnings results on May 11, 2022. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.075 by $0.025.
              Is Savara overvalued?
              According to Wall Street analysts Savara’s price is currently Undervalued.
                Does Savara pay dividends?
                Savara does not currently pay dividends.
                What is Savara’s EPS estimate?
                Savara’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Savara have?
                Savara has 114,040,000 shares outstanding.
                  What happened to Savara’s price movement after its last earnings report?
                  Savara reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.075. Following the earnings report the stock price went up 1.786%.
                    Which hedge fund is a major shareholder of Savara?
                    Among the largest hedge funds holding Savara’s share is Farallon Capital Management, L.L.C.. It holds Savara’s shares valued at 10M.

                      ---

                      Savara Stock Analysis

                      The Savara stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Savara

                      Savara, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Athersys
                      Novartis
                      Bellerophon
                      United Therapeutics
                      PDS Biotechnology

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis